EFung Capital

company

About

Shenzhen EFUNG Investment Management Enterprise is an institution that invests in professional biomedical industries.

  • 11 - 50

Details

Industries
Finance,Financial Services,Venture Capital
Founded date
Jan 1, 1996
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Venture Capital

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VC Institutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investments

Number of Investments
Number of Lead Investments
1
1
EFung Capital has made 1 investments. Their most recent investment was on Oct 9, 2020, when 3D Medicines raised $140M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 9, 2020 3D Medicines
Series Unknown $140M Biopharma Yes